Is it wise to eliminate lymphography from the staging of Hodgkin's disease?

被引:4
作者
Guermazi, A [1 ]
机构
[1] St Louis Univ Hosp, Dept Radiol, F-75013 Paris, France
关键词
lymphography; staging; Hodgkin's disease; lymphoma;
D O I
10.3109/10428190109099326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We believe that lymphography and CT are complementary rather than mutually exclusive techniques for the diagnosis and staging of HD. Unfortunately, it seems that many radiologists and clinicians disregard the ability of lymphography to provide qualitative information on lymph node architecture, which is not available by CT. The use of lymphography is declining in several teaching centers throughout the world. This makes it difficult for young radiologists to acquire the skills needed to perform and interpret lymphographies successfully. In turn. radiologists who have little experience with lymphography are less likely to use the technique. Because most of the treatment-related morbidity in HD is dose-related, and because lymphography helps to avoid over- and undertreatment, we believe that high-quality lymphography continues to have a significant role in the staging of selected HD patients. Moreover, lymphography may reduce both the cost of management and the morbidity rate in many HD patients. One solution would be to continue to use lymphography in a small number of institutions specialized in the management of HD.
引用
收藏
页码:655 / 660
页数:6
相关论文
共 50 条
  • [21] Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease
    Kabickova, Edita
    Sumerauer, David
    Cumlivska, Eliska
    Drahokoupilova, Eva
    Nekolna, Michaela
    Chanova, Marketa
    Hladikova, Marie
    Kodet, Roman
    Belohlavek, Otakar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (09) : 1025 - 1031
  • [22] Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin’s disease
    Edita Kabickova
    David Sumerauer
    Eliska Cumlivska
    Eva Drahokoupilova
    Michaela Nekolna
    Marketa Chanova
    Marie Hladikova
    Roman Kodet
    Otakar Belohlavek
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 1025 - 1031
  • [23] Modern pharmacotherapy of Hodgkin's disease
    Josting, A
    Behringer, K
    Engert, A
    Diehl, V
    INTERNIST, 2004, 45 (01): : 93 - 101
  • [24] Unusual manifestations of Hodgkin's disease
    Roif, M
    Miller, EB
    Kneller, A
    Landau, Z
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (01): : 62 - 63
  • [25] Hodgkin's disease of the thoracic vertebrae
    Uehara, Masashi
    Takahashi, Jun
    Hirabayashi, Hiroki
    Kitahara, Jun
    Kamijyo, Tetsuyoshi
    Ebara, Sohei
    Kato, Hiroyuki
    SPINE JOURNAL, 2013, 13 (08) : E59 - E63
  • [26] Hodgkin's disease
    Ekstrand, BC
    Horning, SJ
    BLOOD REVIEWS, 2002, 16 (02) : 111 - 117
  • [27] Hodgkin's disease
    Diehl, V
    Josting, A
    CANCER JOURNAL, 2000, 6 : S150 - S158
  • [28] Hodgkin's lymphoma: news from an old disease
    Raemaekers, J. M. M.
    van der Maazen, R. W. M.
    NETHERLANDS JOURNAL OF MEDICINE, 2008, 66 (11) : 457 - 466
  • [29] Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease
    Ashigbi, MY
    Venkatraj, U
    Agarwal, V
    Bello, J
    Wiernik, PH
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 28 (04): : 255 - 258
  • [30] Intracranial localization revealing Hodgkin's disease
    Alkhalil, A.
    Elziere, C.
    Kelaidi, C.
    Belin, C.
    Salama, J.
    REVUE NEUROLOGIQUE, 2008, 164 (02) : 200 - 205